You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 151 No. 7, JULY 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  REVIEW ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Human Immunodeficiency Virus Infection and the Skin

A Crucial Interface

Clay J. Cockerell, MD

Arch Intern Med. 1991;151(7):1295-1303.


Abstract

The skin is commonly affected in the course of human immunodeficiency virus (HIV) infection. In many cases, skin findings may be the earliest sign of HIV disease or acquired immunodeficiency syndrome. When cutaneous diseases occur in unusual settings, such as zoster in a young individual, are increased in severity or fail to respond to routine therapy, the possibility of underlying immunodeficiency should be suspected. Skin diseases in HIV-infected hosts include primary infections, such as those caused by herpes simplex virus and molluscum contagiosum, as well as secondary involvement of systemic diseases, such as cryptococcosis and histoplasmosis. Noninfectious inflammatory processes, such as seborrheic dermatitis and psoriasis, as well as neoplasms, such as Kaposi's sarcoma and basal cell carcinoma, may all be seen in these patients. We review a number of these diseases and discuss their treatment. Clinicians must be aware of the cutaneous manifestations of HIV infection so that the disease will be recognized at an earlier point in time and therapy with zidovudine and prophylactic antibiotics will be instituted where appropriate.

(Arch Intern Med. 1991;151:1295-1303)



Author Affiliations

From the Division of Dermatopathology, Departments of Pathology and Dermatology, The University of Texas Southwestern Medical Center, Dallas.


Footnotes

Accepted for publication November 19, 1990.

Reprint requests to Division of Dermatopathology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75235-9072 (Dr Cockerell).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevalence of Cutaneous Disorders in a Population of HIV-Infected Patients: Southwestern France, 1996
Spira et al.
Arch Dermatol 1998;134:1208-1212.
ABSTRACT | FULL TEXT  

The Changing Spectrum of the Cutaneous Manifestations of HIV Disease
Costner and Cockerell
Arch Dermatol 1998;134:1290-1292.
FULL TEXT  

Viral Folliculitis: Atypical Presentations of Herpes Simplex, Herpes Zoster, and Molluscum Contagiosum
Weinberg et al.
Arch Dermatol 1997;133:983-986.
ABSTRACT  

Papulo-Pruritic Eruption and Giant Ulceration of the Mouth: A Difficult Clinical Feature to Treat in the Patient Infected With Human Immunodeficiency Virus
Harindra and Roy
Arch Intern Med 1992;152:1924-1924.
ABSTRACT  

Association Between Porphyria Cutanea Tarda and Human Immunodeficiency Virus Infection
Tebas et al.
Arch Intern Med 1992;152:1726-1726.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.